PRADAXA continues strong market performance 20 months after U.S. FDA approval – PR Newswire

Minimize lapses in therapy. Effect of P-gp Inducers & Inhibitors on Dabigatran Exposure The concomitant use of PRADAXA with P-gp inducers (e.g., rifampin) reduces exposure to dabigatran and should generally be avoided. P-gp inhibition and impaired renal …